Publication | Open Access
Molecular Tumor Board–Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial
25
Citations
22
References
2022
Year
When treated with MTB-directed therapy, most patients experienced improved PFS compared with immediately prior treatment. MTB-directed targeted therapy may be a strategy to improve outcomes for patients with advanced cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1